Screener
Outset Medical, Inc. OM Q2 2026 earnings
Reported August 6, 2026 · After market close
Revenue$31.6MBeat by $2.7M
EPS-$0.80Miss by $0.08
Revenue estimate$29.0M
EPS estimate-$0.72
“Second quarter results reflect continued progress in strengthening the foundation of our business while positioning Outset for the next phase of growth. During the quarter, we completed our highest number of successful new site installations in several years. We also signed our first refresh agreement, which enhances backlog visibility and marks an important milestone as we begin to capitalize on a significant refresh opportunity. By reshaping how dialysis care is delivered across a large market that needs better solutions, Outset is well positioned to accelerate adoption, drive long-term growth and advance toward profitability.”
Next report
Nov 9, 2026 (in a month)Revenue estimate$31.4M
EPS estimate-$0.64
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Outset Medical, Inc. report Q2 2026 earnings?
- Outset Medical, Inc. (OM) reported Q2 2026 earnings on August 6, 2026 after market close.
- What were Outset Medical, Inc.'s Q2 2026 revenue and EPS?
- Outset Medical, Inc. reported revenue of $31.6M and eps of $-0.80 for Q2 2026.
- Did Outset Medical, Inc. beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $29.0M by $2.7M. EPS missed the consensus estimate of $-0.72 by $0.08.
- How did Outset Medical, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 0.7% from $31.4M a year earlier and eps grew 4.8% from $-0.84.
- Where can I find Outset Medical, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-337953) and the 10-Q periodic report (0001193125-26-338432) directly on SEC EDGAR. The filing index links above go to sec.gov.
